Cargando…

Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice

High serum levels of free fatty acids (FFAs) could contribute to obesity-induced nephropathy. CD36, a class B scavenger receptor, is a major receptor mediating FFA uptake in renal proximal tubular cells. Empagliflozin, a new anti-diabetic agent, is a specific inhibitor of sodium-glucose co-transport...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chiang-Chi, Chou, Chia-An, Chen, Wei-Yu, Yang, Jenq-Lin, Lee, Wen-Chin, Chen, Jin-Bor, Lee, Chien-Te, Li, Lung-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621539/
https://www.ncbi.nlm.nih.gov/pubmed/34830289
http://dx.doi.org/10.3390/ijms222212408
_version_ 1784605482881646592
author Huang, Chiang-Chi
Chou, Chia-An
Chen, Wei-Yu
Yang, Jenq-Lin
Lee, Wen-Chin
Chen, Jin-Bor
Lee, Chien-Te
Li, Lung-Chih
author_facet Huang, Chiang-Chi
Chou, Chia-An
Chen, Wei-Yu
Yang, Jenq-Lin
Lee, Wen-Chin
Chen, Jin-Bor
Lee, Chien-Te
Li, Lung-Chih
author_sort Huang, Chiang-Chi
collection PubMed
description High serum levels of free fatty acids (FFAs) could contribute to obesity-induced nephropathy. CD36, a class B scavenger receptor, is a major receptor mediating FFA uptake in renal proximal tubular cells. Empagliflozin, a new anti-diabetic agent, is a specific inhibitor of sodium-glucose co-transporter 2 channels presented on renal proximal tubular cells and inhibits glucose reabsorption. In addition, empagliflozin has shown renoprotective effects. However, the mechanism through which empagliflozin regulates CD36 expression and attenuates FFA-induced lipotoxicity remains unclear. Herein, we aimed to elucidate the crosstalk between empagliflozin and CD36 in FFA-induced renal injury. C57BL/6 mice fed a high-fat diet (HFD) and palmitic acid-treated HK-2 renal tubular cells were used for in vivo and in vitro assessments. Empagliflozin attenuated HFD-induced body weight gain, insulin resistance, and inflammation in mice. In HFD-fed mice, CD36 was upregulated in the tubular area of the kidney, whereas empagliflozin attenuated CD36 expression. Furthermore, empagliflozin downregulated the expression of peroxisome proliferator-activated receptor (PPAR)-γ. Treatment with a PPARγ inhibitor (GW9662) did not further decrease PPARγ expression, whereas a PPARγ antagonist reversed this effect; this suggested that empagliflozin may, at least partly, decrease CD36 by modulating PPARγ. In conclusion, empagliflozin can ameliorate FFA-induced renal tubular injury via the PPARγ/CD36 pathway.
format Online
Article
Text
id pubmed-8621539
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86215392021-11-27 Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice Huang, Chiang-Chi Chou, Chia-An Chen, Wei-Yu Yang, Jenq-Lin Lee, Wen-Chin Chen, Jin-Bor Lee, Chien-Te Li, Lung-Chih Int J Mol Sci Article High serum levels of free fatty acids (FFAs) could contribute to obesity-induced nephropathy. CD36, a class B scavenger receptor, is a major receptor mediating FFA uptake in renal proximal tubular cells. Empagliflozin, a new anti-diabetic agent, is a specific inhibitor of sodium-glucose co-transporter 2 channels presented on renal proximal tubular cells and inhibits glucose reabsorption. In addition, empagliflozin has shown renoprotective effects. However, the mechanism through which empagliflozin regulates CD36 expression and attenuates FFA-induced lipotoxicity remains unclear. Herein, we aimed to elucidate the crosstalk between empagliflozin and CD36 in FFA-induced renal injury. C57BL/6 mice fed a high-fat diet (HFD) and palmitic acid-treated HK-2 renal tubular cells were used for in vivo and in vitro assessments. Empagliflozin attenuated HFD-induced body weight gain, insulin resistance, and inflammation in mice. In HFD-fed mice, CD36 was upregulated in the tubular area of the kidney, whereas empagliflozin attenuated CD36 expression. Furthermore, empagliflozin downregulated the expression of peroxisome proliferator-activated receptor (PPAR)-γ. Treatment with a PPARγ inhibitor (GW9662) did not further decrease PPARγ expression, whereas a PPARγ antagonist reversed this effect; this suggested that empagliflozin may, at least partly, decrease CD36 by modulating PPARγ. In conclusion, empagliflozin can ameliorate FFA-induced renal tubular injury via the PPARγ/CD36 pathway. MDPI 2021-11-17 /pmc/articles/PMC8621539/ /pubmed/34830289 http://dx.doi.org/10.3390/ijms222212408 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huang, Chiang-Chi
Chou, Chia-An
Chen, Wei-Yu
Yang, Jenq-Lin
Lee, Wen-Chin
Chen, Jin-Bor
Lee, Chien-Te
Li, Lung-Chih
Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title_full Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title_fullStr Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title_full_unstemmed Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title_short Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
title_sort empagliflozin ameliorates free fatty acid induced-lipotoxicity in renal proximal tubular cells via the pparγ/cd36 pathway in obese mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621539/
https://www.ncbi.nlm.nih.gov/pubmed/34830289
http://dx.doi.org/10.3390/ijms222212408
work_keys_str_mv AT huangchiangchi empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT chouchiaan empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT chenweiyu empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT yangjenqlin empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT leewenchin empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT chenjinbor empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT leechiente empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice
AT lilungchih empagliflozinamelioratesfreefattyacidinducedlipotoxicityinrenalproximaltubularcellsviatheppargcd36pathwayinobesemice